Hormonal Contraceptive Market Size, Share, Growth Analysis, By Type(Progestin-only contraceptives and combined hormonal contraceptives), By Product(Oral contraceptive pills, intrauterine devices (IUD), injectable birth control, vaginal rings and others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2132 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 62 |Figures: 80

Hormonal Contraceptive Market Insights

Hormonal Contraceptive Market size was valued at USD 16.98 billion in 2021 and is poised to grow from USD 17.3 billion in 2022 to USD 24.2 billion by 2030, growing at a CAGR of 4.31% in the forecast period (2023-2030).

Hormonal contraceptives are highly effective at preventing pregnancy when used correctly, but they do not protect against sexually transmitted infections (STIs). Therefore, it's important to use additional methods of protection, such as condoms, if you are at risk for STIs. These can also have side effects, such as headaches, nausea, breast tenderness, and changes in menstrual bleeding patterns, so it's important to talk to your healthcare provider about the risks and benefits before choosing a method.

The global hormonal contraceptive market is a rapidly growing industry, expected to grow at a compound annual growth rate (CAGR) of approximately 4.5% from 2022 to 2030. The growth of the market is driven by increasing awareness and acceptance of contraceptives, the rising prevalence of sexually transmitted infections, and the growing demand for effective family planning methods. Among the different types of hormonal contraceptives, oral contraceptives are the most widely used, accounting for the largest share of the market. The combination pills segment, which contains both oestrogen and progestin hormones, holds the largest market share due to their effectiveness and convenience of use. However, the progestin-only pills segment is expected to grow at a faster rate due to their lower risk of side effects and suitability for women who cannot take oestrogen.

US Hormonal Contraceptive Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 16.98 billion

Largest Segment

Combined hormonal contraceptives

Fastest Growth

Combined hormonal contraceptives

Growth Rate

4.31% CAGR

Global Hormonal Contraceptive Market 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)

To get more reports on the above market click here to Buy The Report

Hormonal Contraceptive Market Segmental Analysis

Global Hormonal Contraceptive Market is segmented on the basis of type, product and region. By type, the market is segmented into progestin-only contraceptives and combined hormonal contraceptives. By product, market is segmented into oral contraceptive pills, intrauterine devices (IUD), injectable birth control, vaginal rings and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Hormonal Contraceptive Market Analysis by Type

The combined hormonal contraceptives segment holds the largest market share due to their widespread availability, high effectiveness rates, and convenience of use. Combined hormonal contraceptives contain both estrogen and progestin hormones. They work by suppressing ovulation and thickening the cervical mucus to prevent fertilization. Combined hormonal contraceptives are available in different forms, including pills, patches, vaginal rings, and injections.

The progestin-only contraceptives segment is expected to grow at a faster rate due to their lower risk of side effects and suitability for women who cannot take estrogen. Progestin-only contraceptives are also known as mini-pills and contain only the hormone progestin. Progestin-only contraceptives work by thickening the cervical mucus, which makes it difficult for sperm to reach the egg. They are a popular choice for women who cannot take estrogen due to medical reasons, such as breastfeeding mothers or women with a history of blood clots.

Hormonal Contraceptive Market Analysis by Product

The largest segment of the Global Hormonal Contraceptive Market by product is the Oral Contraceptive Pills segment. Oral contraceptive pills are one of the most popular forms of hormonal contraceptives. These pills contain a combination of hormones, such as estrogen and progestin, which prevent pregnancy by stopping ovulation. The global market for oral contraceptive pills is projected to grow at a significant rate due to their ease of use, low cost, and high effectiveness. Additionally, oral contraceptive pills are available in various formulations, such as monophasic, biphasic, triphasic, and quadriphasic pills, providing women with a wide range of options.

The fastest-growing segment of the Global Hormonal Contraceptive Market is the Injectable Birth Control segment. The market for injectable birth control is projected to grow at a significant rate due to its high efficacy, ease of use, and long-lasting effects. Injectable are popular among women who prefer a method that does not require daily attention and are also effective for those who may have difficulty remembering to take a daily pill. The convenience and long-lasting effect of injectable make them an attractive option for women who want reliable contraception with minimal effort.

Global Hormonal Contraceptive Market Size By Type 2022(%)

To get detailed analysis on other segments, Request For Free Sample Report

Hormonal Contraceptive Market Regional Insights

North America is the largest market for hormonal contraceptives, driven by the high awareness and adoption of contraception in the region. There is a high level of awareness and adoption of hormonal contraceptives in North America, with a large percentage of women using some form of contraception. This is driven by factors such as education, access to healthcare, and cultural acceptance of contraception. There is a wide range of hormonal contraceptive options available in North America, including birth control pills, patches, injections, vaginal rings, and intrauterine devices (IUDs). This gives women a choice of options to suit their needs and preferences. The market in North America is regulated by strong regulatory bodies such as the FDA in the US, which ensures that products are safe and effective before they can be marketed to consumers. North America has one of the highest levels of healthcare spending in the world, which ensures that hormonal contraceptives are widely available and accessible to women.

The Asia-Pacific region is expected to be the fastest-growing market for hormonal contraceptives. There is a growing awareness and adoption of hormonal contraceptives in Asia-Pacific, particularly in countries such as China and India. This is driven by factors such as rising healthcare awareness, increasing access to healthcare, and the changing socio-cultural norms around family planning. Asia-Pacific has the world's largest population, which creates a significant market for hormonal contraceptives. As the region continues to experience demographic shifts, with a growing population of women of reproductive age, the demand for hormonal contraceptives is expected to rise. Several countries in Asia-Pacific have introduced government initiatives to increase access to and adoption of these contraceptives. For example, the Indian government has launched several programs to improve family planning services and increase access to contraceptives. The rising disposable income in many countries in Asia-Pacific is expected to increase the demand for these contraceptives, as women have more access to healthcare services and can afford to pay for contraception.

Global Hormonal Contraceptive Market Size By Geography, 2022-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Hormonal Contraceptive Market Dynamics

Hormonal Contraceptive Market Drivers

Growing Awareness and Acceptance of Contraception

  • One of the major drivers of the global hormonal contraceptive market is the increasing awareness and acceptance of contraception as a means of family planning. With rising population levels, particularly in developing countries, there is a growing need for effective birth control methods to help couples manage their family size and spacing. This has led to a significant increase in the adoption of hormonal contraceptives, as they are highly effective in preventing unintended pregnancies and offer a convenient and reversible method of birth control.

Technological Advancements and Product Innovation

  • Another key driver of the global hormonal contraceptive market is the continuous innovation and development of new contraceptive products and technologies. Manufacturers are investing heavily in research and development to develop new products that offer improved efficacy, safety, and convenience while minimizing side effects and risks. For example, new delivery methods such as patches, vaginal rings, and injectable are being developed, which offer women more options and flexibility in selecting a contraceptive method that suits their lifestyle and preferences. Additionally, advances in drug delivery technologies and formulations are leading to the development of more effective and longer-lasting hormonal contraceptives, which are expected to drive the growth of the market in the coming years.

Hormonal Contraceptive Market Restraints

Social and cultural factors

  • One of the significant restraints of the global hormonal contraceptive market is the social and cultural factors that restrict women's access to contraceptives. Many cultures and societies view contraception negatively, and some religious beliefs prohibit the use of contraceptives. In addition, there is a lack of awareness and education about contraception in many parts of the world, which can lead to low demand for these products. These factors can limit the growth of the hormonal contraceptive market, especially in regions where social and cultural factors play a significant role in the decision to use contraceptives.

Side effects and health risks

  • Hormonal contraceptives are associated with various side effects and health risks. For example, some women may experience headaches, weight gain, nausea, and mood changes when using hormonal contraceptives. In rare cases, these may increase the risk of blood clots, stroke, and breast cancer. These side effects and health risks may deter some women from using these contraceptives, limiting the market's growth. Additionally, concerns about the safety and efficacy of these contraceptives can also impact the market's growth, especially in regions with high levels of distrust towards pharmaceutical products.

Request Free Customization of this report to help us to meet your business objectives.

Hormonal Contraceptive Market Competitive Landscape

The global hormonal contraceptive market is highly competitive, with several established players and a number of new entrants vying for market share. The key companies offer a range of hormonal contraceptive products, including birth control pills, patches, injections, vaginal rings, and intrauterine devices (IUDs). In addition to product offerings, companies in the market compete on factors such as pricing, distribution, marketing, and research and development.

Hormonal Contraceptive Market Top Player’s Company Profiles

  • Pfizer Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Novartis International AG
  • Lupin Pharmaceuticals, Inc.
  • HLL Lifecare Limited
  • Mithra Pharmaceuticals
  • Ferring Pharmaceuticals
  • Afaxys, Inc.
  • Agile Therapeutics
  • Apothecus Pharmaceutical Corp.
  • Piramal Enterprises Ltd.
  • TherapeuticsMD, Inc.
  • CooperSurgical, Inc.
  • Watson Pharmaceuticals, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Janssen Pharmaceutical NV

Hormonal Contraceptive Market Recent Developments

  • In July 2022, Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA launched NEXTSTELLIS in Australia. NEXTSTELLIS is an oral contraceptive that combines two active ingredients: estetrol (E4) and drospirenone. Estetrol is a natural estrogen produced by the fetal liver during pregnancy, and it has a unique profile that makes it different from other estrogens used in hormonal contraceptives. Estetrol has a weaker binding affinity to the estrogen receptor than other estrogens, which means it is less likely to stimulate breast tissue and other estrogen-sensitive tissues. This makes it a promising candidate for use in hormonal contraceptives.
  • In January 2022, the National Population and Family Planning Agency in Indonesia launched a new birth control pill called Progestin, which is safe for nursing mothers to use. The goal of this initiative is to encourage exclusive breastfeeding, which can help prevent infant stunting and promote healthy growth and development.
  • In July 2022, the Organon Group of companies announced that they had entered into a license agreement with Cirqle Biomedical for a novel investigational non-hormonal on-demand preventive product. Organon is a global healthcare company that focuses on women's health, and the agreement reflects its commitment to developing innovative options for women.
  • In May 2021, Allergan announced that it had received approval from the European Commission for its new contraceptive patch called Twirla. Twirla is a once-weekly contraceptive patch that contains both estrogen and progestin.
  • In April 2021, Merck & Co. announced that the U.S. Food and Drug Administration (FDA) had approved a new long-acting injectable contraceptive called Annovera. Annovera is a small, flexible ring that is inserted into the vagina and provides contraceptive protection for up to a year.

Hormonal Contraceptive Key Market Trends

  • Increasing Preference for Long-Acting Reversible Contraceptives (LARCs): One of the key trends in the global hormonal contraceptive market is the increasing popularity of LARCs such as intrauterine devices (IUDs) and subdermal implants. LARCs are highly effective in preventing unintended pregnancies and can last for several years, providing women with a convenient and hassle-free contraceptive option. As a result, there has been a growing demand for LARCs, particularly among younger women and those seeking a more reliable contraceptive method.
  • Rising Demand for Personalized Contraceptive Options: Another trend in the global hormonal contraceptive market is the increasing demand for personalized contraceptive options. With the growing awareness of the side effects and risks associated with hormonal contraceptives, many women are looking for more personalized and tailored contraceptive options. This has led to the development of new products such as hormonal patches, vaginal rings, and progestin-only pills, which offer women more flexibility and choice in selecting a contraceptive method that suits their individual needs and preferences. Additionally, the use of technology such as mobile apps and wearable is allowing women to track their menstrual cycles and identify their fertility windows, further facilitating personalized contraceptive choices.

Hormonal Contraceptive Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our Global Hormonal Contraceptive Market analysis, among the different types of hormonal contraceptives, oral contraceptives are the most widely used, accounting for the largest share of the market. North America held the largest market share due to high awareness and adoption rates of contraceptives, well-established healthcare infrastructure, and favourable government policies. However, the Asia Pacific region is expected to grow at the fastest rate due to the increasing population, rising awareness of family planning methods, and government initiatives to promote contraception. Major players in the global market are investing in research and development to develop new and more effective hormonal contraceptive products to cater to the growing demand.

Report Metric Details
Market size value in 2023 USD 16.98 billion
Market size value in 2031 USD 24.2 billion
Growth Rate 4.31%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Progestin-only contraceptives and combined hormonal contraceptives
  • Product
    • Oral contraceptive pills, intrauterine devices (IUD), injectable birth control, vaginal rings and others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Pfizer Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Novartis International AG
  • Lupin Pharmaceuticals, Inc.
  • HLL Lifecare Limited
  • Mithra Pharmaceuticals
  • Ferring Pharmaceuticals
  • Afaxys, Inc.
  • Agile Therapeutics
  • Apothecus Pharmaceutical Corp.
  • Piramal Enterprises Ltd.
  • TherapeuticsMD, Inc.
  • CooperSurgical, Inc.
  • Watson Pharmaceuticals, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Janssen Pharmaceutical NV

Hormonal Contraceptive Market Recent Developments

  • In July 2022, Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA launched NEXTSTELLIS in Australia. NEXTSTELLIS is an oral contraceptive that combines two active ingredients: estetrol (E4) and drospirenone. Estetrol is a natural estrogen produced by the fetal liver during pregnancy, and it has a unique profile that makes it different from other estrogens used in hormonal contraceptives. Estetrol has a weaker binding affinity to the estrogen receptor than other estrogens, which means it is less likely to stimulate breast tissue and other estrogen-sensitive tissues. This makes it a promising candidate for use in hormonal contraceptives.
  • In January 2022, the National Population and Family Planning Agency in Indonesia launched a new birth control pill called Progestin, which is safe for nursing mothers to use. The goal of this initiative is to encourage exclusive breastfeeding, which can help prevent infant stunting and promote healthy growth and development.
  • In July 2022, the Organon Group of companies announced that they had entered into a license agreement with Cirqle Biomedical for a novel investigational non-hormonal on-demand preventive product. Organon is a global healthcare company that focuses on women's health, and the agreement reflects its commitment to developing innovative options for women.
  • In May 2021, Allergan announced that it had received approval from the European Commission for its new contraceptive patch called Twirla. Twirla is a once-weekly contraceptive patch that contains both estrogen and progestin.
  • In April 2021, Merck & Co. announced that the U.S. Food and Drug Administration (FDA) had approved a new long-acting injectable contraceptive called Annovera. Annovera is a small, flexible ring that is inserted into the vagina and provides contraceptive protection for up to a year.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Hormonal Contraceptive Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Hormonal Contraceptive Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Hormonal Contraceptive Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Hormonal Contraceptive Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Hormonal Contraceptive Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Hormonal Contraceptive Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Hormonal Contraceptive Market size was valued at USD 16.98 billion in 2021 and is poised to grow from USD 17.3 billion in 2022 to USD 24.2 billion by 2030, growing at a CAGR of 4.31% in the forecast period (2023-2030).

The hormonal contraceptive market is highly competitive, with several established players and a number of new entrants vying for market share. The key companies offer a range of hormonal contraceptive products, including birth control pills, patches, injections, vaginal rings, and intrauterine devices (IUDs). In addition to product offerings, companies in the market compete on factors such as pricing, distribution, marketing, and research and development. 'Pfizer Inc.', 'Bayer AG', 'Merck & Co., Inc.', 'Allergan plc', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V.', 'Novartis International AG', 'Lupin Pharmaceuticals, Inc.', 'HLL Lifecare Limited', 'Mithra Pharmaceuticals', 'Ferring Pharmaceuticals', 'Afaxys, Inc.', 'Agile Therapeutics', 'Apothecus Pharmaceutical Corp.', 'Piramal Enterprises Ltd.', 'TherapeuticsMD, Inc.', 'CooperSurgical, Inc.', 'Watson Pharmaceuticals, Inc.', 'Glenmark Pharmaceuticals Ltd.', 'Janssen Pharmaceutical NV', 'In July 2022, Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA launched NEXTSTELLIS in Australia. NEXTSTELLIS is an oral contraceptive that combines two active ingredients: estetrol (E4) and drospirenone. Estetrol is a natural estrogen produced by the fetal liver during pregnancy, and it has a unique profile that makes it different from other estrogens used in hormonal contraceptives. Estetrol has a weaker binding affinity to the estrogen receptor than other estrogens, which means it is less likely to stimulate breast tissue and other estrogen-sensitive tissues. This makes it a promising candidate for use in hormonal contraceptives.', 'In January 2022, the National Population and Family Planning Agency in Indonesia launched a new birth control pill called Progestin, which is safe for nursing mothers to use. The goal of this initiative is to encourage exclusive breastfeeding, which can help prevent infant stunting and promote healthy growth and development.', 'In July 2022, the Organon Group of companies announced that they had entered into a license agreement with Cirqle Biomedical for a novel investigational non-hormonal on-demand preventive product. Organon is a healthcare company that focuses on women's health, and the agreement reflects its commitment to developing innovative options for women.', 'In May 2021, Allergan announced that it had received approval from the European Commission for its new contraceptive patch called Twirla. Twirla is a once-weekly contraceptive patch that contains both estrogen and progestin.', 'In April 2021, Merck & Co. announced that the U.S. Food and Drug Administration (FDA) had approved a new long-acting injectable contraceptive called Annovera. Annovera is a small, flexible ring that is inserted into the vagina and provides contraceptive protection for up to a year.'

One of the major drivers of the hormonal contraceptive market is the increasing awareness and acceptance of contraception as a means of family planning. With rising population levels, particularly in developing countries, there is a growing need for effective birth control methods to help couples manage their family size and spacing. This has led to a significant increase in the adoption of hormonal contraceptives, as they are highly effective in preventing unintended pregnancies and offer a convenient and reversible method of birth control.

Increasing Preference for Long-Acting Reversible Contraceptives (LARCs): One of the key trends in the hormonal contraceptive market is the increasing popularity of LARCs such as intrauterine devices (IUDs) and subdermal implants. LARCs are highly effective in preventing unintended pregnancies and can last for several years, providing women with a convenient and hassle-free contraceptive option. As a result, there has been a growing demand for LARCs, particularly among younger women and those seeking a more reliable contraceptive method.

North America is the largest market for hormonal contraceptives, driven by the high awareness and adoption of contraception in the region. There is a high level of awareness and adoption of hormonal contraceptives in North America, with a large percentage of women using some form of contraception. This is driven by factors such as education, access to healthcare, and cultural acceptance of contraception. There is a wide range of hormonal contraceptive options available in North America, including birth control pills, patches, injections, vaginal rings, and intrauterine devices (IUDs). This gives women a choice of options to suit their needs and preferences. The market in North America is regulated by strong regulatory bodies such as the FDA in the US, which ensures that products are safe and effective before they can be marketed to consumers. North America has one of the highest levels of healthcare spending in the world, which ensures that hormonal contraceptives are widely available and accessible to women.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35I2132

$5,300
BUY NOW GET FREE SAMPLE